Si prevede che il mercato del sequenziamento e dei test dei miRNA raggiungerà i 468,99 milioni di dollari entro il 2027 rispetto ai 192,31 milioni di dollari del 2019; si stima che crescerà a un CAGR dell'11,9% dal 2020 al 2027.
miRNA è una piccola molecola di RNA non codificante di lunghezza pari a 20-30 nucleotidi e svolge un ruolo importante nella regolazione genetica. Poiché è parzialmente complementare all’RNA messaggero (mRNA), svolge la funzione principale di sottoregolare l’espressione genica, il che lo rende un controllore chiave di importanti funzioni cellulari. I miRNA sono associati a processi patologici come infezioni virali, malattie autoimmuni e carcinogenesi. Pertanto, sono in corso ricerche approfondite per identificare nuovi miRNA. La crescita del mercato del sequenziamento e dei test dei miRNA è principalmente attribuita a fattori quali l’ampliamento della gamma di applicazioni dei miRNA e l’aumento dei finanziamenti per la ricerca genomica. Tuttavia, si prevede che le sfide relative alla somministrazione, all'efficacia e alla specificità delle terapie basate sui miRNA scoraggeranno la crescita del mercato.
Regioni redditizie per il mercato del sequenziamento e dei test dei miRNA
Approfondimenti di mercato
Ampliamento della gamma di applicazioni dei microRNA
I miRNA sono un gruppo di piccole molecole di RNA non codificanti di 20-30 nucleotidi lunghezza. Queste molecole si legano a un RNA messaggero bersaglio (mRNA) e portano al silenziamento genico, controllando così l'espressione genica. Pertanto, svolgono un ruolo fondamentale nella fisiologia e nello sviluppo cellulare. I miRNA regolano tutte le funzioni cellulari come la proliferazione cellulare, la differenziazione e l'apoptosi. Essendo coinvolti nel processo di differenziazione, svolgono un ruolo cruciale nell'offrire l'identità dei tessuti. Pertanto, si ritiene che i miRNA siano un indicatore utile per identificare i tipi di cellule.
Inoltre, i miRNA sono anche associati a processi patologici come infezioni virali, malattie autoimmuni e carcinogenesi. Alcuni di essi possono agire come oncogeni (oncomiR), mentre molti altri agiscono come miRNA soppressori del tumore. L'alterata espressione dei miRNA è correlata alla comparsa di diversi tipi di cancro. Si sta esplorando il potenziale dei miRNA, combinato con le tecnologie di sequenziamento di prossima generazione, come nuova classe di biomarcatori del cancro. Si prevede che abbiano un ruolo vitale da svolgere nella valutazione dello sviluppo, della progressione, della prognosi, della diagnosi e del trattamento del cancro. Inoltre, diverse classi di miRNA sono emerse come biomarcatori promettenti per malattie infettive causate da agenti patogeni, tra cui HIV, virus Hendra, tubercolosi e malaria.
Inoltre, la scoperta relativa al ruolo dei miRNA nello sviluppo delle malattie ha fatto miRNA un bersaglio chiave di nuovi approcci terapeutici. Diverse terapie mirate ai miRNA contro malattie come il cancro e l’epatite hanno raggiunto la fase clinica. Ad esempio, Santaris Pharma ha sviluppato una molecola terapeutica denominata Miravirsen che prende di mira il miR-122 per il trattamento dell'infezione da virus dell'epatite C (HCV); la molecola è nella sperimentazione clinica di Fase II. Pertanto, la crescente gamma di applicazioni dei miRNA sta guidando la crescita del mercato del sequenziamento e dei test dei miRNA.
Approfondimenti basati sul prodotto
Il mercato del sequenziamento e dei test dei miRNA, per prodotto, è segmentato in preparazione della biblioteca e materiali di consumo. Il segmento dei materiali di consumo ha detenuto una quota maggiore del mercato nel 2019, mentre si prevede che il segmento della preparazione delle biblioteche registrerà un CAGR più elevato nel mercato durante il periodo di previsione.
miRNA Mercato del sequenziamento e del dosaggio, per prodotto - 2019 e 2027
Approfondimenti basati sulla tecnologia
Basato sulla tecnologia, il mercato del sequenziamento e dei test dei miRNA è segmentato in sequenziamento per sintesi, nanopori e semiconduttori ionici sequenziamento. Il segmento del sequenziamento per sintesi ha detenuto la quota maggiore di mercato nel 2019; tuttavia, si prevede che il segmento dei nanopori registrerà il CAGR più elevato del mercato nel corso del 2020-2027.
Approfondimenti basati sull'utente finale
Basato su utente finale, il mercato del sequenziamento e dei test dei miRNA è segmentato in istituti di ricerca, mondo accademico e CRO. Il segmento degli istituti di ricerca ha detenuto la quota maggiore del mercato nel 2019 e si stima che registrerà il CAGR più elevato del mercato nel periodo dal 2020 al 2027.
Approfondimenti strategici
La collaborazione è una delle principali strategie adottate dagli operatori del mercato del sequenziamento e dei test miRNA per ampliare la base di clienti in tutto il mondo, consentendo loro anche di mantenere il proprio marchio a livello globale.
miRNA Sequencing and Mercato dei test - per prodotto
- Preparazione della libreria
- Consumabili
Mercato del sequenziamento e analisi dei miRNA - per tecnologia
- Sequenziamento per sintesi
- Nanopori
- Sequenziamento di semiconduttori ionici
Mercato del sequenziamento e dei test di miRNA - ; per utente finale
- Istituto di ricerca
- Accademia
- CRO
Mercato del sequenziamento e dei test miRNA - per area geografica
- Nord America
- Stati Uniti
- Canada
- Messico
< li>Europa - Francia
- Germania
- Italia
- Regno Unito
- Spagna
- Resto dell'Europa
- Asia Pacifico (APAC)
- Cina
- India
- Corea del Sud
- Giappone
- Australia
- Resto dell'Asia Pacifico
- Medio Oriente e Africa (MEA)
- Sudafrica
- Arabia Saudita
- Emirati Arabi Uniti
- Resto del Medio Oriente e dell'Africa
- Sud e America Centrale
- Brasile
- Argentina
- Resto dell'America centrale e meridionale
  ;
Profili aziendali
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Qiagen
- Perkin Elmer Inc.
- Takara Bio Inc.
- New England Biolabs
- NorgenBiotek Corp
- TriLinkBioTechnologies Inc
- Lexogen GmbH
- Oxford Nanopore Technologies
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
miRNA is a small non-coding RNA molecule of 20–30-nucleotide length, and it plays an important role in gene regulation. As it is partially complementary to messenger RNA (mRNA), it serves a major function of down-regulating the gene expression, which makes it a key controller of important cellular functions. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. Thus, extensive research is being conducted to identify new miRNAs.
The growth of the miRNA sequencing and assay market is mainly attributed to the factors such widening range of miRNA applications and rise in funding for genomics research. However, challenges related to delivery, efficacy, and specificity of miRNA-based therapeutics is projected to deter the market growth.
The GMP cytokines market majorly consists of the players such as Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen, Perkin Elmer, Inc., Takara Bio Inc., New England Biolabs, Norgen Biotek Corp, TriLink BioTechnologies Inc, Lexogen GmbH, and Oxford Nanopore Technologies among others.
The List of Companies - MiRNA Sequencing And Assay Market
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Qiagen
- Perkin Elmer Inc.
- Takara Bio Inc.
- New England Biolabs
- NorgenBiotek Corp
- TriLinkBioTechnologies Inc
- Lexogen GmbH
- Oxford Nanopore Technologies
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Feb 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Feb 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Feb 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Feb 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)